Are European stocks finally outperforming Wall Street?
European share prices started the year on a positive note, trading at lower valuations, but analysts caution against confirming a trend shift
Promising new gene therapies for sickle cell are out of reach in countries where they’re needed most
AP|
The one-time treatment is out of reach in India and Africa — places where the disease is most common. Vast inequities cut much of the world off from gene therapy in general
Who wins and who loses with the end of patents on biopharmaceuticals?
A number of important drugs will lose their exclusivity, paving the way for generics and biosimilars
Top 10 pharma companies have over $120 billion in cash for mergers and acquisitions
Drug companies like BMS, GSK and Amgen face revenue losses from patent expirations
Pfizer will spend $43 billion to acquire Seagen
AP|
The pharmaceutical giant said Monday that it will pay $229 per Seagen share